Anesthesia Drugs Market - Top Companies and Manufacturers

  • Report ID: 5842
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Anesthesia Drugs Market

    • Hikma Pharmaceuticals Plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories
    • GE Healthcare
    • Aspen Pharmacare Holdings Limited
    • Avet Pharmaceuticals, Inc.
    • Par Pharmaceuticals
    • Teva Pharmaceuticals
    • Novartis AG
    • Heron Pharmaceutical, Inc.
    • Piramal Enterprises Limited

Browse Key Market Insights with Data Illustration:

In the News

  • GE Healthcare was granted the FDA pre-market clearance (PMA) to, a multinational healthcare and medical technology business with headquarters in the United States, for its End-tidal (Et) control software, which is used to provide general anesthesia on the Aisys CS2 Anesthesia Delivery System. In addition to the benefits low-flow anesthesia provides for hospitals and the environment, the device has direct control over the end-tidal concentration, which reflects the medication level in the patient's blood.
  • Hikma Pharmaceuticals PLC introduced midazolam injectable pouches containing 0.9% sodium chloride (NaCl) in dosages of 50 mg/50 mL and 100 mg/100 mL. In the US, the medication is authorized for continuous intravenous infusion for sedating adults, children, and newborns who are ventilated and oxygen-deprived during anesthesia or therapy in a critical care setting.

Author Credits:  Radhika Pawar


  • Report ID: 5842
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anesthesia drugs is evaluated at USD 7.34 billion.

The anesthesia drugs market size was over USD 7.12 billion in 2024 and is poised to exceed USD 11.56 billion by 2037, growing at over 3.8% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by increasing number of surgical procedures performed worldwide.

North America industry is poised to dominate majority revenue share of 33% by 2037, due to rising number of people suffering from chronic illnesses in the region.

The major players in the market include Hikma Pharmaceuticals Plc, Abbott Laboratories, GE Healthcare, Aspen Pharmacare Holdings Limited, Avet Pharmaceuticals, Inc., Par Pharmaceuticals, Teva Pharmaceuticals, Novartis AG, Heron Pharmaceutical, Inc., Piramal Enterprises Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample